GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » EV-to-Revenue

China Health Industries Holdings (China Health Industries Holdings) EV-to-Revenue : 587.62 (As of May. 11, 2024)


View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, China Health Industries Holdings's enterprise value is $68.75 Mil. China Health Industries Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12 Mil. Therefore, China Health Industries Holdings's EV-to-Revenue for today is 587.62.

The historical rank and industry rank for China Health Industries Holdings's EV-to-Revenue or its related term are showing as below:

CHHE' s EV-to-Revenue Range Over the Past 10 Years
Min: -916.25   Med: -1.19   Max: 1801.13
Current: 587.62

During the past 13 years, the highest EV-to-Revenue of China Health Industries Holdings was 1801.13. The lowest was -916.25. And the median was -1.19.

CHHE's EV-to-Revenue is ranked worse than
99.12% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs CHHE: 587.62

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), China Health Industries Holdings's stock price is $2.05. China Health Industries Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, China Health Industries Holdings's PS Ratio for today is 1,025.00.


China Health Industries Holdings EV-to-Revenue Historical Data

The historical data trend for China Health Industries Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings EV-to-Revenue Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 -0.59 -3.54 - 176.50

China Health Industries Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -792.91 -525.77 176.50 1,345.12 321.26

Competitive Comparison of China Health Industries Holdings's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's EV-to-Revenue falls into.



China Health Industries Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

China Health Industries Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=68.751/0.117
=587.62

China Health Industries Holdings's current Enterprise Value is $68.75 Mil.
China Health Industries Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Industries Holdings  (OTCPK:CHHE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

China Health Industries Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.05/0.002
=1,025.00

China Health Industries Holdings's share price for today is $2.05.
China Health Industries Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Industries Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Industries Holdings (China Health Industries Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
Sun Xin director, 10 percent owner, officer: CEO, CFO and Treasurer NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing director, officer: Secretary 2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson director 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster director 402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn director, officer: COO 422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee 10 percent owner 3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems 10 percent owner, officer: President, CEO, CFO and, other: Secretary 1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines